Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
10.1007/s10549-010-0788-0
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-110766 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1107662024-11-10T22:52:58Z Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer Barrios, C.H. Liu, M.-C. Lee, S.C. Vanlemmens, L. Ferrero, J.-M. Tabei, T. Pivot, X. Iwata, H. Aogi, K. Lugo-Quintana, R. Harbeck, N. Brickman, M.J. Zhang, K. Kern, K.A. Martin, M. CANCER SCIENCE INSTITUTE OF SINGAPORE Advanced breast cancer Capecitabine Sunitinib malate Tyrosine kinase inhibitor 10.1007/s10549-010-0788-0 Breast Cancer Research and Treatment 121 1 121-131 BCTRD 2014-11-26T09:59:59Z 2014-11-26T09:59:59Z 2010-05 Article Barrios, C.H., Liu, M.-C., Lee, S.C., Vanlemmens, L., Ferrero, J.-M., Tabei, T., Pivot, X., Iwata, H., Aogi, K., Lugo-Quintana, R., Harbeck, N., Brickman, M.J., Zhang, K., Kern, K.A., Martin, M. (2010-05). Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer. Breast Cancer Research and Treatment 121 (1) : 121-131. ScholarBank@NUS Repository. https://doi.org/10.1007/s10549-010-0788-0 01676806 http://scholarbank.nus.edu.sg/handle/10635/110766 000276758200012 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Advanced breast cancer Capecitabine Sunitinib malate Tyrosine kinase inhibitor |
| spellingShingle |
Advanced breast cancer Capecitabine Sunitinib malate Tyrosine kinase inhibitor Barrios, C.H. Liu, M.-C. Lee, S.C. Vanlemmens, L. Ferrero, J.-M. Tabei, T. Pivot, X. Iwata, H. Aogi, K. Lugo-Quintana, R. Harbeck, N. Brickman, M.J. Zhang, K. Kern, K.A. Martin, M. Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| description |
10.1007/s10549-010-0788-0 |
| author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
| author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Barrios, C.H. Liu, M.-C. Lee, S.C. Vanlemmens, L. Ferrero, J.-M. Tabei, T. Pivot, X. Iwata, H. Aogi, K. Lugo-Quintana, R. Harbeck, N. Brickman, M.J. Zhang, K. Kern, K.A. Martin, M. |
| format |
Article |
| author |
Barrios, C.H. Liu, M.-C. Lee, S.C. Vanlemmens, L. Ferrero, J.-M. Tabei, T. Pivot, X. Iwata, H. Aogi, K. Lugo-Quintana, R. Harbeck, N. Brickman, M.J. Zhang, K. Kern, K.A. Martin, M. |
| author_sort |
Barrios, C.H. |
| title |
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| title_short |
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| title_full |
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| title_fullStr |
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| title_full_unstemmed |
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer |
| title_sort |
phase iii randomized trial of sunitinib versus capecitabine in patients with previously treated her2-negative advanced breast cancer |
| publishDate |
2014 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/110766 |
| _version_ |
1821211954173181952 |